The Research Of Venture Capital On China’s Biological Pharmaceutical Industry

21 century is the century of biotechnology, with the rapidly development ofCell biology, Immunology, Genetics and bioinformatics, Biological pharmaceuticalindustry has changed tremendously. In recent years, as the "Twelfth Five-Year" Planfor biological industry started, biological research and development accelerated, thedomestic demand of medicine expanded, our country gradually pay attention to thedevelopment of biological pharmacy.Biological pharmaceutical industry as a high and new technology, Initialinvestment is Relatively high, the cycle of biological research and development islong, the risk is strong. With its lack of security and mortgage, bank loans is more andmore difficult. So its suitable for venture capital invest in each stage of biologicalpharmaceutical industry. This requires the biological pharmaceutical enterprisesunderstanding their factors of attracting venture capital, and Understanding howimportant these factors are.By consulting related documents and books of venture capital and biological pharmaceutical,and by the analysis of biological pharmaceutical industry of our country present situation andthe characteristics of the industry, this article may apply principal component analysis method, onthe basis of the data In the《2009 high and new technology statistics yearbook》and《the riskinvestment yearbook》, analyzing the biological pharmaceutical industry’s ability of attractingventure capital. Summarizing the factors of attracting venture capital of China biologicalpharmaceutical industry. At last, based on the results of the analysis, Given some advice onbiological pharmaceutical industry in our country for their better attracting venture capital.